Skip to main content
BioMaxima S.A. logo

BioMaxima S.A. — Investor Relations & Filings

Ticker · BMX ISIN · PLBIOMX00015 LEI · 2594007GAALFMXP4YB89 WAR Manufacturing
Open in API
Filings indexed 616 across all filing types
Latest filing 2025-04-30 Annual Report
Country PL Poland
Listing WAR BMX

About BioMaxima S.A.

https://www.biomaxima.com/

BioMaxima S.A. is a manufacturer specializing in in-vitro diagnostics. The company's primary activities include the development and production of a wide range of products for laboratory diagnostics, with a focus on clinical microbiology. Key product categories include microbiological media, various diagnostic reagents, and specialized laboratory equipment. In addition to its manufacturing operations, BioMaxima also serves as a distributor for products from other global diagnostics firms. The company is actively involved in product innovation, including the development of Minimum Inhibitory Concentration (MIC) tests for antibiotic susceptibility testing.

Recent filings

Filing Released Lang Actions
Ocena Rady Nadzorczej dotycząca sprawozdań grupy
Annual Report Classification · 100% confidence The document is an XHTML file containing XBRL tags (Consolia XBRL Tools), which is the standard format for electronic financial reporting in the European Union (ESEF). The filename 'BMX_GK_RN-2024-12-31-0-pl.xhtml' indicates it is a consolidated annual report ('GK' stands for 'Grupa Kapitałowa' - Capital Group, 'RN' stands for 'Raport Roczny' - Annual Report) for the fiscal year ending 2024-12-31. As it contains the full financial statements and is not merely an announcement, it is classified as an Annual Report (10-K). FY 2024
2025-04-30 Polish
Oświadczenie Rady Nadzorczej w sprawie Komitetu Audytu
Audit Report / Information Classification · 95% confidence The document text provided is highly technical, consisting primarily of HTML structure, CSS styling definitions, and font embedding data (WOFF format base64 encoding). The title tag contains 'BMX_KA_-2024-12-31-0-pl.xhtml', suggesting a filing related to a specific date (December 31, 2024) and possibly a Polish entity ('pl'). Crucially, the document is not the content of a financial report, earnings release, or management discussion. Instead, it appears to be the raw, converted output of a document processing tool (pdf2htmlEX) used to render an underlying document, likely a regulatory filing or report, into an HTML format. Since the actual content of the report is not present, and this is merely the structural wrapper/conversion artifact, it does not fit any specific financial reporting category (10-K, ER, IR, etc.). Therefore, the most appropriate classification is the general fallback category for miscellaneous or non-standard regulatory/data files that don't fit elsewhere, which is Regulatory Filings (RNS). The document length is substantial (883,946 chars), suggesting the underlying document was large, but the provided text is the container, not the content. FY 2024
2025-04-30 Polish
Podpis do sprawozdania z badania
Audit Report / Information Classification · 98% confidence The provided document text consists almost entirely of XML signature blocks, specifically containing elements like 'Signature', 'SignedInfo', 'Reference', 'DigestValue', 'SignatureValue', 'KeyInfo', and 'X509Certificate'. This structure is characteristic of digitally signed documents, often used to ensure the integrity and authenticity of official regulatory filings or reports. One of the references within the signature block points to a URI containing Polish text: 'KPW Audyt - sprawozdanie z badania Skonsolidowane.xhtml'. The Polish phrase 'sprawozdanie z badania Skonsolidowane' translates to 'Consolidated Audit Report'. Given the content is the digital signature wrapper for a document explicitly named as a 'Consolidated Audit Report', the most appropriate classification is 'Audit Report / Information' (AR), as it directly relates to the audit findings of consolidated financial statements. FY 2024
2025-04-30 Polish
Sprawozdanie z badania przez Biegłego
Audit Report / Information Classification · 98% confidence The provided document text is extremely short (relative to the 129k character total length, but the provided snippet is very small) and appears to be the raw HTML/XML structure of a document, including metadata, CSS styles, and conversion notes (e.g., "This file was converted to xhtml by OpenOffice.org"). There are no discernible financial keywords, regulatory headers (like 10-K, AR, ER), or specific reporting periods that would allow classification into a standard financial filing type (10-K, IR, ER, etc.). The content is primarily structural boilerplate from a file conversion process. Given the lack of substantive financial content and the nature of the text being structural/metadata, the most appropriate fallback category is 'Regulatory Filings' (RNS) as a general catch-all for unclassifiable regulatory artifacts, although 'XLSX' might be considered if this were clearly a data file, but the structure suggests a converted document rather than raw data. Since it's not a clear report, but rather a structural wrapper, RNS is the safest fallback. Q1 2025
2025-04-30 Polish
Podpisy do Sprawozdania Zarządu
Regulatory Filings Classification · 95% confidence The provided document text consists almost entirely of XML structures detailing digital signatures (Signatures, SignedInfo, SignatureValue, KeyInfo, X509Data, etc.). This structure is characteristic of an electronically signed document, often accompanying a formal regulatory filing or report, rather than the report content itself. The presence of references to a file named "GK_BioMaxima-2024-12-31-0-pl.xhtml" and the overall nature of the content (digital certificate validation) strongly suggest this is metadata or a signature block attached to a primary document. Since the document is not the report content (like 10-K or IR) but rather the mechanism verifying its authenticity, and given the context of corporate filings, the most appropriate classification is a general Regulatory Filing (RNS) or, if we interpret the signature block as the primary content provided, it might be related to a specific type of filing that heavily relies on digital signing, but RNS serves as the best general category for non-content regulatory artifacts or miscellaneous filings. However, since the document length is substantial (15,879 chars) and it contains multiple complex signatures, it is likely the signature block *of* a major filing, but without the content of that filing, we default to the most general regulatory category that captures non-standard content, which is RNS. If this were a short announcement *about* the filing, it would be RPA. Since it is the signature block itself, RNS is the most fitting fallback for this technical artifact.
2025-04-30 Polish
Sprawozdanie Zarządu z działalności Grupy Kapitałowej
Audit Report / Information Classification · 95% confidence The document text provided is an HTML structure containing extensive CSS styling and metadata related to a PDF conversion tool ('pdf2htmlEX'). The title tag indicates 'GK_BioMaxima-2024-12-31-0-pl.xhtml'. The document length is very large (2.4 million characters), suggesting it is the full content of a report, not just an announcement. The filename structure (Company-Date-Period) strongly suggests a periodic financial filing. Since the document is comprehensive and not merely an announcement of a report, and given the large size, it is likely a full financial report. However, without explicit keywords like '10-K', 'Annual Report', or 'Interim Report', and given the Polish language context ('pl' in the title), the most appropriate classification for a comprehensive, non-specific periodic financial filing that isn't explicitly an Annual Report (10-K) or Interim Report (IR) is often the general 'Regulatory Filing' (RNS) or, if it's a comprehensive annual document, 10-K. Given the date '2024-12-31', this is likely an annual filing. Since the content is the full report structure (not an RPA), and it's a comprehensive filing, I will lean towards the most comprehensive category that fits a full annual filing if 10-K is not explicitly confirmed, or IR if it's a half-year report. Since the date is year-end (Dec 31), it is an annual filing. In the absence of explicit '10-K' headers, and assuming this is a comprehensive annual filing from a non-US entity (implied by 'pl' extension), the best fit among the comprehensive reports is either 10-K or IR. Given the year-end date, 10-K is the standard equivalent for a full annual report. If it were a quarterly/half-year report, it would be IR. I will classify it as 10-K based on the year-end date, assuming it represents the full annual filing. FY 2024
2025-04-30 Polish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.